Management of erectile dysfunction secondary to treatment for localized prostate cancer.
BACKGROUND
Management options for localized prostate cancer include radical prostatectomy, external radiation therapy, brachytherapy, and watchful waiting. Improvements in treatment techniques have resulted in fewer side effects. Nevertheless, long-term complications such as erectile dysfunction (ED) continue to affect a significant percentage of men treated for prostate cancer and can have a distressing and debilitating effect on the patient's quality of life.


METHODS
The author reviews both the prevalence and the current options for the management of ED secondary to treatment for clinically localized prostate cancer.


RESULTS
The ability to preserve potency after prostate cancer treatment is controversial, with reports ranging from 10%-90%. For patients complaining of impotence, efficacious alternatives are available such as oral drugs, intraurethral alprostadil, vacuum devices, intracavernous injections, and penile prostheses.


CONCLUSIONS
Sexual function is an integral part of patient satisfaction and quality of life. Although ED is a frequent complication of definitive treatment of localized prostate cancer, a variety of treatment options are now available to maximize quality of life despite age and other comorbidities.
Telöken
C
C
Department of Urology, Fund Fac Federal Ciencias Medicas, cep 90480-003, Porto Alegre, Brazil. cteloken@hotmail.com
D000367:Age Factors; D007172:Erectile Dysfunction / Q000209:etiology* / Q000628:therapy*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D011468:Prostatectomy / Q000009:adverse effects*; D011471:Prostatic Neoplasms / Q000532:radiotherapy* / Q000601:surgery*; D011788:Quality of Life; D011878:Radiotherapy / Q000009:adverse effects; D011795:Surveys and Questionnaires; D016896:Treatment Outcome